Legislation (HR 6752, S 3396) recently introduced in the House and Senate would create a program to provide physicians with unbiased information about prescription drug drugs, CQ HealthBeat reports. The alleged "academic particularisation" program is part of an drive by lawmakers to change the human relationship between physicians and the pharmaceutical industry, according to Ashley Glacel, a voice for Sen. Herb Kohl (D-Wis.), wHO introduced the Senate measure. Reps. Frank Pallone (D-N.J.) and Henry Waxman (D-Calif.) introduced the companion eyeshade in the House.
Kohl in a acquittance said that the current system of physicians getting information on drugs from pharmaceutical industry representatives is "fraught with conflicts of interest." The measure would give federal funding for prescription drug education that would be objective and unbiased. Pallone said it would give physicians the information required to "prescribe the to the highest degree effective treatment to their patients."
Pharmaceutical Research and Manufacturers of America Senior Vice President Ken Johnson aforementioned "the opinion that physician prescribing is overwhelmingly determined by pharmaceutical company outreach is non accurate." Industry representatives aforesaid that other factors help guide physicians' prescribing, such as a patient's aesculapian history, clinical guidelines and influence from peers. In addition, Johnson said that industry representatives must follow FDA regulations when promoting drugs and that the academic particularisation programs would not be held to the like standards.
Glacel aforementioned that although time is limited this year for passage of the measures, they mightiness be connected to other legislation. She also said that if the legislation is non passed this year, the lawmakers will pursue the bills once again next year (Parnass, CQ HealthBeat, 8/5).
South Carolina Pilot Program
In related news, the South Carolina Department of Health and Human Services and the South Carolina College of Pharmacy have launched a pilot programme that aims to cultivate physicians wHO treat Medicaid beneficiaries around the most cost-effective treatments, the Columbia State reports. Through the academic particularization program, pharmacists visit doctor offices to give doctors research-based information that is not influenced by pharmaceutical companies. According to a 2007 review article of 69 studies, even short, former interactions between pharmacists and physicians potty improve patient care, with up to 6% of physicians changing how they practiced after such meetings.
Program Director Sarah Ball aforementioned, "If it is effective, the ultimate outcome will be better health forethought and improved cost-effectiveness." State officials do not experience whether the program testament reduce drug costs, simply they do expect a savings in overall res publica health care costs.
The $2 jillion, two-year pilot film project is staffed by four pharmacists who see physicians in six counties that account for around one-third of the state's 625,000 Medicaid beneficiaries. The program began with the pharmacists visiting family line physicians and psychiatrists, as psychiatric drugs account for more than 25% of Medicaid's do drugs costs. If effective, the program could be expanded statewide (Reid, Columbia State, 8/4).
Reprinted with kind license from hypertext transfer protocol://www.kaisernetwork.org. You can purview the full Kaiser Daily Health Policy Report, search the archives, or mark up for email bringing at hTTP://www.kaisernetwork.
